Zhengye Biotechnology Holding (ZYBT) Raw Materials (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Raw Materials for 3 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Raw Materials rose 8.17% year-over-year to $1.1 million in Q4 2025; TTM through Dec 2025 was $1.1 million, a 8.17% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 11.38% from the prior year.
• Raw Materials was $1.1 million for Q4 2025 at Zhengye Biotechnology Holding, up from $1.0 million in the prior quarter.
• Over five years, Raw Materials peaked at $1.4 million in Q4 2023 and troughed at $1.0 million in Q4 2024.
• A 3-year average of $1.2 million and a median of $1.1 million in 2025 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials retreated 24.54% in 2024 and grew 8.17% in 2025, its largest moves.
• Over 3 years, Raw Materials stood at $1.4 million in 2023, then dropped by 24.54% to $1.0 million in 2024, then advanced by 8.17% to $1.1 million in 2025.
• The last three Raw Materials figures came in at $1.1 million (Q4 2025), $1.0 million (Q4 2024), and $1.4 million (Q4 2023), per Business Quant data.